These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 18088247

  • 1. Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay.
    Ferraro D, Giglio M, Bonura C, Di Marco V, Mondelli MU, Craxì A, Di Stefano R.
    J Viral Hepat; 2008 Jan; 15(1):66-70. PubMed ID: 18088247
    [Abstract] [Full Text] [Related]

  • 2. Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a.
    Sarrazin C, Hendricks DA, Sedarati F, Zeuzem S.
    J Clin Microbiol; 2001 Aug; 39(8):2850-5. PubMed ID: 11474002
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Discordance between HCV RNA assays for week 24 HCV RNA determination during pegylated interferon-α/ribavirin treatment for chronic hepatitis C.
    Roomer R, van Vuuren AJ, Schutten M, Heijens A, Janssen HL, de Knegt RJ.
    Antivir Ther; 2011 Aug; 16(5):771-4. PubMed ID: 21817199
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.
    Tsubota A, Arase Y, Someya T, Suzuki Y, Suzuki F, Saitoh S, Ikeda K, Akuta N, Hosaka T, Kobayashi M, Kumada H.
    J Med Virol; 2005 Jan; 75(1):27-34. PubMed ID: 15543591
    [Abstract] [Full Text] [Related]

  • 8. Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy.
    Sarrazin C, Shiffman ML, Hadziyannis SJ, Lin A, Colucci G, Ishida H, Zeuzem S.
    J Hepatol; 2010 Jun; 52(6):832-8. PubMed ID: 20385421
    [Abstract] [Full Text] [Related]

  • 9. Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients.
    Crespo M, Esteban JI, Ribera E, Falco V, Sauleda S, Buti M, Esteban R, Guardia J, Ocaña I, Pahissa A.
    AIDS; 2007 Feb 19; 21(4):477-81. PubMed ID: 17301566
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
    Napoli N, Giannelli G, Parisi CV, Antonaci A, Maddalena G, Antonaci S.
    New Microbiol; 2005 Jan 19; 28(1):13-21. PubMed ID: 15782622
    [Abstract] [Full Text] [Related]

  • 12. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
    Hanouneh IA, Miller C, Aucejo F, Lopez R, Quinn MK, Zein NN.
    Liver Transpl; 2008 Jan 19; 14(1):53-8. PubMed ID: 18161839
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.
    Martinot-Peignoux M, Khiri H, Leclere L, Maylin S, Marcellin P, Halfon P.
    J Clin Virol; 2009 Nov 19; 46(3):216-21. PubMed ID: 19748822
    [Abstract] [Full Text] [Related]

  • 15. Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.
    Halfon P, Pénaranda G, Bourlière M, Khiri H, Masseyeff MF, Ouzan D.
    J Med Virol; 2006 Feb 19; 78(2):208-15. PubMed ID: 16372298
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
    Neff GW, O'Brien CB, Cirocco R, Montalbano M, de Medina M, Ruiz P, Khaled AS, Bejarano PA, Safdar K, Hill MA, Tzakis AG, Schiff ER.
    Liver Transpl; 2004 May 19; 10(5):595-8. PubMed ID: 15108250
    [Abstract] [Full Text] [Related]

  • 18. The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response.
    Napoli N, Giannelli G, Antonaci A, Antonaci S.
    J Viral Hepat; 2008 Apr 19; 15(4):300-4. PubMed ID: 18307592
    [Abstract] [Full Text] [Related]

  • 19. [Predicting sustained virological response in chronic hepatitis C patients treated with pegylated interferon and ribavirin using a novel highly sensitive Real-time detection PCR assay].
    Matsuura K, Tanaka Y, Takagi K, Hiramatsu K, Kani S, Gotoh T, Wakimoto Y, Joh T, Mizokami M.
    Rinsho Byori; 2007 Nov 19; 55(11):983-8. PubMed ID: 18154028
    [Abstract] [Full Text] [Related]

  • 20. Optimizing outcomes in patients with hepatitis C virus genotype 1 or 4.
    Lee SS, Ferenci P.
    Antivir Ther; 2008 Nov 19; 13 Suppl 1():9-16. PubMed ID: 18432158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.